Maria Rita Fontana

This inventor holds 13 USPTO granted patents and 4 published patent applications and 7 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Vaccines and Diagnostics Srl, Novartis Ag. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Rita Fontana. Retrieved from https://idiyas.com/inventor/maria-rita-fontana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 61.5

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 143(Granted Patents)

Location History:

Sienna, IT (2014)
Siena, IT (2009 - 2021)

Company Filing History:

5 out of 545

Glaxosmithkline Biologicals Sa

patents

5 out of 47

Novartis Vaccines and Diagnostics Srl

J. Craig Venter Institute

patents

5. 1 out of 1

J. Craig Venture Institute, Inc.

patent

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988511 - Conservedbacterial IG-like domain (group 1) protein (ORF405) immunogens (2021-04-27),

2. 10058600 - [object Object] (2018-08-28),

3. 10035826 - [object Object] (2018-07-31),

4. 9334313 - [object Object] (2016-05-10),

5. 9101560 - [object Object] (2015-08-11),

6. 8871214 - [object Object] (2014-10-28),

7. 8758764 - [object Object] (2014-06-24),

8. 8642050 - Gonococcal proteins and nucleic acids (2014-02-04),

9. 8470341 - [object Object] (2013-06-25),

10. 8062644 - [object Object] (2011-11-22),

11. 7872114 - Immunogenic detoxified mutants of cholera toxin (2011-01-18),

12. 7632513 - Immunogenic detoxified mutants of cholera toxin (2009-12-15),

13. 7504111 - Gonococcal proteins and nucleic acids (2009-03-17),

Title: Maria Rita Fontana: Innovator in Immunogen Research

Introduction

Maria Rita Fontana is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of immunogen research, holding a total of 13 patents. Her work focuses on developing innovative solutions to combat various pathogenic strains.

Latest Patents

Among her latest patents, Fontana has developed immunogens related to conserved bacterial IG-like domain proteins. These include homologs of proteins such as orf353, orf405, and flu antigen 43. Additionally, she has identified detoxified variants of the pathogenic AcfD precursor that maintain a similar immune response as the native protein. Her research emphasizes the importance of immunogenic fragments, particularly linear B-epitopes, which are crucial for effective immune responses.

Career Highlights

Fontana has worked with notable companies in the pharmaceutical and biotechnology sectors, including Novartis Vaccines and Diagnostics and GlaxoSmithKline Biologicals. Her expertise in immunogen development has positioned her as a key figure in advancing vaccine research and development.

Collaborations

Throughout her career, Fontana has collaborated with esteemed colleagues such as Mariagrazia Pizza and Danilo Gomes Moriel. These partnerships have further enhanced her research and contributed to her success in the field.

Conclusion

Maria Rita Fontana's innovative work in immunogen research has led to significant advancements in vaccine development. Her contributions continue to impact the field positively, showcasing her dedication to improving public health through scientific innovation.

Profile summary based on public USPTO records.